$BMSN -- REGEN BIOPHARMA AVOIDS WASTE OF "ONE PR
Post# of 102233
$BMSN -- REGEN BIOPHARMA AVOIDS WASTE OF "ONE PRODUCT/ONE INFRASTRUCTURE" APPROACH
In the "Conventional Model", stem cell companies are started with one basic technology, infrastructure is developed around that technology, then if the technology fails, significant resources are lost that have been used in the product-specific development